tiprankstipranks
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market

Compare Tarsus Pharmaceuticals (TARS) vs. Competitors

266 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Tarsus Pharmaceuticals
$72.56
$3.09B
-51.51
64.46%
8 Buy
1 Hold
0 Sell
Strong Buy
Denali Therapeutics
$19.23
$3.05B
-5.63
53.84%
13 Buy
1 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$24.21
$3.00B
-228.91
80.13%
8 Buy
1 Hold
0 Sell
Strong Buy
Beam Therapeutics
$27.43
$2.68B
2.92
87.49%
11 Buy
1 Hold
0 Sell
Strong Buy
Disc Medicine
$66.32
$2.53B
-13.21
88.25%
11 Buy
0 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$3.28
$1.73B
-2.84
-27.27%
1 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TARS
Tarsus Pharmaceuticals
72.56
26.13
56.28%
DNLI
Denali Therapeutics
19.23
6.53
51.42%
ARQT
Arcutis Biotherapeutics
24.21
11.62
92.30%
BEAM
Beam Therapeutics
27.43
11.96
77.31%
IRON
Disc Medicine
66.32
27.59
71.24%
RXRX
Recursion Pharmaceuticals
3.28
-2.48
-43.06%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts